{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:22:35Z","timestamp":1778750555830,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Only a limited number of animal studies have demonstrated the neuroprotective effects of single dose of ceftriaxone (CTX) in traumatic brain injury (TBI). Consequently, the present study seeks to fill these research gaps by examining the impact of CTX on neurological and motor performance, brain edema, and blood\u2013brain barrier (BBB) permeability in a rat model of severe diffuse TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Ninety-eight male Albino Wistar rats were subjected to TBI using the Marmarou method. The rats were divided into seven groups, each consisting of 14 animals: Intact, Sham, TBI, Vehicle (TBI + saline placebo injection), and three groups receiving single intraperitoneal (IP) injections of CTX at doses of 100, 200, and 400 mg\/kg. Post-trauma assessments included measurements of the brain water content (BWC), BBB permeability, Veterinary Coma Scale (VCS), beam-walk (BW), beam-balance (BB), IL-10, IL-1\u03b2, TNF-\u03b1, and INF-\u03b3 concentrations, liver and kidney function tests, and histopathological analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Administration of CTX at doses of 100 and 200 mg\/kg resulted in significantly reduced BWC, enhanced BBB integrity, improved VCS scores, better performance on BW and BB tests, reduced IL-1\u03b2, TNF-\u03b1, and INF-\u03b3, and increased IL-10, along with favorable histopathological outcomes and no signs of systemic toxicity. However, increasing the dose to 400 mg\/kg did not yield further improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our results demonstrate that CTX administration at doses of 100 and 200 mg\/kg significantly improved neurological and motor function, reduced cerebral edema, enhanced blood-brain barrier integrity, and favorably modulated the post-traumatic inflammatory response. In contrast, the 400 mg\/kg dose conferred no additional benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000004376","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:00:13Z","timestamp":1764000013000},"page":"266-277","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Neuroprotective effects of ceftriaxone after severe traumatic brain injury in male rats: a behavioral, biochemical, and histological study"],"prefix":"10.1097","volume":"88","author":[{"given":"Amirhossein","family":"Esfahani","sequence":"first","affiliation":[{"name":"School of Medicine, Ramsar Campus, Mazandaran University of Medical Sciences, Ramsar, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7505-3148","authenticated-orcid":false,"given":"Ali","family":"Siahposht-Khachaki","sequence":"additional","affiliation":[{"name":"Deparment of Physiology, Immunogenetics Research Center, Mazandaran University of Medical Sciences, Sari, Iran"},{"name":"Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iram."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Talebpour Amiri","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohid","family":"Emami Meybodi","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran"},{"name":"Functional Neurosurgery Research Center, Research Institute of Functional Neurosurgery, Shohada Tajrish Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-8343","authenticated-orcid":false,"given":"Mobina","family":"Gheibi","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, Razi Hospital, Mazandaran University of Medical Sciences, Sari, Iran"},{"name":"Student Research Committee, School of Allied Medical Sciences, Mazandaran University of Medical Sciences, Sari, Iran"},{"name":"Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3903-0464","authenticated-orcid":false,"given":"Erfan","family":"Ghadirzadeh","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran"},{"name":"Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Biabani","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazal","family":"Taghipour","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Sciences, School of Pharmacy, Mazandaran University of Medical Sciences, Ramsar, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asal","family":"Safarbalou","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Sciences, School of Pharmacy, Mazandaran University of Medical Sciences, Ramsar, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Farzin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"1326115","DOI":"10.3389\/fnbeh.2024.1326115","article-title":"Traumatic brain injuries: a neuropsychological review","volume":"18","author":"Chan","year":"2024","journal-title":"Front Behav Neurosci"},{"key":"R3-20260514","first-page":"558","article-title":"Prevalence of traumatic brain injury in the general adult population of the USA: a meta-analysis","author":"Karamian","year":"2025","journal-title":"Neuroepidemiology"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"1725\u201342","DOI":"10.1007\/s12031-021-01841-7","article-title":"Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets","volume":"71","author":"Thapa","year":"2021","journal-title":"J Mol Neurosci"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"309\u201341","DOI":"10.3390\/ijms15010309","article-title":"Traumatic brain injury pathophysiology and treatments: early, intermediate, and late phases post-injury","volume":"15","author":"Algattas","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"695\u2013700","DOI":"10.1007\/s10072-013-1585-4","article-title":"Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury","volume":"35","author":"Cui","year":"2014","journal-title":"Neurol Sci"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"1131\u201355","DOI":"10.1177\/0963689717714092","article-title":"Repeated mild traumatic brain injury: potential mechanisms of damage","volume":"26","author":"Fehily","year":"2017","journal-title":"Cell Transplant"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"497\u2013507","DOI":"10.1089\/neu.2009.1120","article-title":"In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury","volume":"27","author":"Frugier","year":"2010","journal-title":"J Neurotrauma"},{"key":"R9-20260514","doi-asserted-by":"crossref","first-page":"215\u201322","DOI":"10.1111\/j.1750-3639.2004.tb00056.x","article-title":"Cell death mechanisms following traumatic brain injury","volume":"14","author":"Raghupathi","year":"2004","journal-title":"Brain Pathology"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"1984\u20132011","DOI":"10.2174\/1570159X19666210215123914","article-title":"The complexity of secondary cascade consequent to traumatic brain injury: pathobiology and potential treatments","volume":"19","author":"Khatri","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"133\u201343","DOI":"10.1002\/glia.10310","article-title":"Glutamate transporter expression and function in human glial progenitors","volume":"45","author":"Maragakis","year":"2004","journal-title":"Glia"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"101838","DOI":"10.1016\/j.arr.2022.101838","article-title":"Glutamatergic neurotransmission: a potential pharmacotherapeutic target for the treatment of cognitive disorders","volume":"85","author":"Chakraborty","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R13-20260514","first-page":"567\u201373","article-title":"Novel approach to the role of NMDA receptors in traumatic brain injury","volume":"13","author":"Shohami","year":"2014","journal-title":"CNS Neurol Disord Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"key":"R14-20260514","doi-asserted-by":"crossref","first-page":"108602","DOI":"10.1016\/j.neuropharm.2021.108602","article-title":"Glutamate transporters: critical components of glutamatergic transmission","volume":"192","author":"Rodr\u00edguez-Campuzano","year":"2021","journal-title":"Neuropharmacology"},{"key":"R15-20260514","doi-asserted-by":"crossref","first-page":"107559","DOI":"10.1016\/j.neuropharm.2019.03.002","article-title":"The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: potential targets for neurotherapeutics","volume":"161","author":"Pajarillo","year":"2019","journal-title":"Neuropharmacology"},{"key":"R16-20260514","doi-asserted-by":"crossref","first-page":"1224\u201338","DOI":"10.2174\/1570159X15666170613083606","article-title":"Recent advances in pathophysiology of traumatic brain injury","volume":"16","author":"Kaur","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"R17-20260514","doi-asserted-by":"crossref","first-page":"1\u201314","DOI":"10.1186\/s12868-021-00659-8","article-title":"Ceftriaxone therapy attenuates brain trauma in rats by affecting glutamate transporters and neuroinflammation and not by its antibacterial effects","volume":"22","author":"Lim","year":"2021","journal-title":"BMC Neurosci"},{"key":"R18-20260514","doi-asserted-by":"crossref","first-page":"73\u201377","DOI":"10.1038\/nature03180","article-title":"\u03b2-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"R19-20260514","doi-asserted-by":"crossref","first-page":"4506\u201318","DOI":"10.1093\/cercor\/bhy328","article-title":"Ceftriaxone treatment preserves cortical inhibitory interneuron function via transient salvage of GLT-1 in a rat traumatic brain injury model","volume":"29","author":"Hameed","year":"2019","journal-title":"Cereb Cortex"},{"key":"R20-20260514","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/ars.2021.0094","article-title":"Autophagy and apoptosis in acute brain injuries: from mechanism to treatment","volume":"38","author":"He","year":"2023","journal-title":"Antioxid Redox Signal"},{"key":"R21-20260514","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s11010-025-05207-0","article-title":"Autophagy and the peroxisome proliferator-activated receptor signaling pathway: a molecular ballet in lipid metabolism and homeostasis","volume":"480","author":"Kiani","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"R22-20260514","doi-asserted-by":"crossref","first-page":"841036","DOI":"10.3389\/fnins.2022.841036","article-title":"Ceftriaxone as a novel therapeutic agent for hyperglutamatergic states: bridging the gap between preclinical results and clinical translation","volume":"16","author":"Abulseoud","year":"2022","journal-title":"Front Neurosci"},{"key":"R23-20260514","doi-asserted-by":"crossref","first-page":"94\u201399","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"1","author":"Kilkenny","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"R24-20260514","article-title":"Marmarou weight drop injury model. In: Chen J, Xu ZC, Xu XM, Zhang JH, eds. Animal Models of Acute Neurological Injuries. Springer Protocols Handbooks","author":"Marmarou","year":"2009","journal-title":"Humana Press"},{"key":"R25-20260514","doi-asserted-by":"crossref","first-page":"1135\u201344","DOI":"10.1007\/s11011-020-00594-3","article-title":"Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway","volume":"35","author":"Rahimi","year":"2020","journal-title":"Metab Brain Dis"},{"key":"R26-20260514","doi-asserted-by":"crossref","first-page":"1151660","DOI":"10.3389\/fneur.2023.1151660","article-title":"Models of traumatic brain injury-highlights and drawbacks","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Neurol"},{"key":"R27-20260514","doi-asserted-by":"crossref","first-page":"230\u201338","DOI":"10.1016\/j.jss.2024.01.002","article-title":"Murine traumatic brain injury model comparison: closed head injury versus controlled cortical impact","volume":"296","author":"Baucom","year":"2024","journal-title":"J Surg Res"},{"key":"R28-20260514","article-title":"The controlled cortical impact model of experimental brain trauma: overview, research applications, and protocol. In: Kobeissy F, Dixon C, Hayes R, Mondello S, eds. Injury Models of the Central Nervous System. Methods in Molecular Biology","author":"Osier","year":"2016","journal-title":"New York, NY: Humana Press"},{"key":"R29-20260514","doi-asserted-by":"crossref","first-page":"115943","DOI":"10.1016\/j.bbr.2025.115943","article-title":"The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study","volume":"499","author":"Ghadirzadeh","journal-title":"Behav Brain Res"},{"key":"R30-20260514","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12883-024-04017-z","article-title":"Neuroprotective effects of quercetin on hippocampal CA1 neurons following middle cerebral artery ischemia\u2012reperfusion in male rats: a behavioral, biochemical, and histological study","volume":"25","author":"Mahyar","year":"2025","journal-title":"BMC Neurol"},{"key":"R31-20260514","doi-asserted-by":"crossref","first-page":"1434\u201341","DOI":"10.1089\/neu.2012.2712","article-title":"Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat","volume":"30","author":"Goodrich","year":"2013","journal-title":"J Neurotrauma"},{"key":"R32-20260514","doi-asserted-by":"crossref","first-page":"177\u201382","DOI":"10.1161\/01.STR.0000252091.36912.65","article-title":"Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation","volume":"38","author":"Chu","year":"2007","journal-title":"Stroke"},{"key":"R33-20260514","first-page":"507029","article-title":"Glutamate transporter GLT-1 upregulation attenuates visceral nociception and hyperalgesia via spinal mechanisms not related to anti-inflammatory or probiotic effects","volume":"2011","author":"Lin","year":"2011","journal-title":"Pain Res Treat"},{"key":"R34-20260514","doi-asserted-by":"crossref","first-page":"798\u2013800","DOI":"10.1126\/science.2567056","article-title":"The role of excitatory amino acids and NMDA receptors in traumatic brain injury","volume":"244","author":"Faden","year":"1989","journal-title":"Science"},{"key":"R35-20260514","doi-asserted-by":"crossref","first-page":"2178\u201389","DOI":"10.1046\/j.1471-4159.2000.0752178.x","article-title":"Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates","volume":"75","author":"Tyurin","year":"2000","journal-title":"J Neurochem"},{"key":"R36-20260514","doi-asserted-by":"crossref","first-page":"654\u201360","DOI":"10.1097\/TA.0b013e31825133c0","article-title":"The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury","volume":"73","author":"Wei","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"R37-20260514","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/biomedicines12040781","article-title":"Clinical management in traumatic brain injury","volume":"12","author":"Yan","year":"2024","journal-title":"Biomedicines"},{"key":"R38-20260514","doi-asserted-by":"crossref","first-page":"430\u201346","DOI":"10.1007\/s12028-017-0408-5","article-title":"Medical management of the severe traumatic brain injury patient","volume":"27","author":"Marehbian","year":"2017","journal-title":"Neurocrit Care"},{"key":"R39-20260514","doi-asserted-by":"crossref","first-page":"1\u20138","DOI":"10.32587\/jnic.2022.00486","article-title":"Intensive care unit management of traumatic brain injury patients","volume":"5","author":"Konar","year":"2022","journal-title":"J Neurointensive Care"},{"key":"R40-20260514","doi-asserted-by":"crossref","first-page":"375\u201385","DOI":"10.1016\/S2213-2600(23)00471-X","article-title":"Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial","volume":"12","author":"Dahyot-Fizelier","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R41-20260514","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:00:47Z","timestamp":1778749247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004376","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"2025-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}